The Birth, and Evolution, of Percutaneous Coronary Interventions: A Conversation With Patrick Serruys, MD, PhD.

作者信息

Serruys Patrick W, Rutherford John D

出版信息

Circulation. 2016 Jul 12;134(2):97-100. doi: 10.1161/CIRCULATIONAHA.116.023681.

DOI:10.1161/CIRCULATIONAHA.116.023681

PMID:27400895

Abstract

摘要

相似文献

The Birth, and Evolution, of Percutaneous Coronary Interventions: A Conversation With Patrick Serruys, MD, PhD.

Circulation. 2016 Jul 12;134(2):97-100. doi: 10.1161/CIRCULATIONAHA.116.023681.

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):440-9. doi: 10.1016/j.jcin.2015.10.042. Epub 2016 Jan 6.

Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.

Circ Cardiovasc Interv. 2015 Nov;8(11):e002778. doi: 10.1161/CIRCINTERVENTIONS.115.002778.

The role of drug-eluting stents for the treatment of coronary chronic total occlusions.

Expert Rev Cardiovasc Ther. 2013 Oct;11(10):1349-58. doi: 10.1586/14779072.2013.838142.

Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds.

Int J Cardiol. 2016 Mar 1;206:58-60. doi: 10.1016/j.ijcard.2016.01.091. Epub 2016 Jan 7.

Drug-eluting versus bare-metal coronary stents: where are we now?

J Comp Eff Res. 2012 Nov;1(6):501-8. doi: 10.2217/cer.12.64.

40 Years on.

Eur Heart J. 2017 Jul 21;38(28):2158-2160. doi: 10.1093/eurheartj/ehx333.

Dexamethasone-eluting vascular stents.

Basic Clin Pharmacol Toxicol. 2013 May;112(5):296-301. doi: 10.1111/bcpt.12056. Epub 2013 Mar 9.

Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.

Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.002372.

Long-term effect of second-generation drug-eluting stents for coronary artery disease, everolimus-eluting versus zotarolimus-eluting stents: a meta-analysis.

Coron Artery Dis. 2015 May;26(3):259-65. doi: 10.1097/MCA.0000000000000222.

引用本文的文献

Comparison of machine learning models with conventional statistical methods for prediction of percutaneous coronary intervention outcomes: a systematic review and meta-analysis.

BMC Cardiovasc Disord. 2025 Apr 23;25(1):310. doi: 10.1186/s12872-025-04746-0.

Evaluation of Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in an All-Comers Patient Population: 1-Year Results of the S-FLEX Slovakia Registry.

Anatol J Cardiol. 2024 Mar;28(3):142-149. doi: 10.14744/AnatolJCardiol.2023.3801.

Global research trends in in-stent neoatherosclerosis: A CiteSpace-based visual analysis.

Front Cardiovasc Med. 2022 Nov 8;9:1025858. doi: 10.3389/fcvm.2022.1025858. eCollection 2022.

Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis.

Cardiol J. 2023;30(4):556-566. doi: 10.5603/CJ.a2022.0071. Epub 2022 Aug 1.

Stent visualization methods to guide percutaneous coronary interventions and assess long-term patency.

World J Cardiol. 2021 Sep 26;13(9):416-437. doi: 10.4330/wjc.v13.i9.416.

Drug-Coated Balloon for De Novo Coronary Artery Lesions: A Systematic Review and Trial Sequential Meta-analysis of Randomized Controlled Trials.

Cardiovasc Ther. 2020 Aug 10;2020:4158363. doi: 10.1155/2020/4158363. eCollection 2020.

Coronary stents and vascular response to implantation: literature review.

Pragmat Obs Res. 2017 Jul 13;8:137-148. doi: 10.2147/POR.S132439. eCollection 2017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验